NCI Bypass Budget Request For FY 1982Seeks $1.192 Billion; Would Fund 40% Of Competing R01s
In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List
NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears
NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC
DeVita Recommends Carcinogenesis Testing Program Be Moved to NIEHS
NCAB Opposes Line Item for Centers
Trending Stories
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated